Clinical trial

The Effectiveness of Small Doses of Ketamine With Morphine on Decreasing Pain Responses During Open Wound Care

Name
H2280-32187-01
Description
This is a randomized double-blind study to determine if the administration of a small-dose of ketamine (an anesthetic)added to morphine (an opioid) contributes to reducing pain intensity during open wound care procedure (WCP)in patients who have had a traumatic injury and are in an Intensive Care Unit. Patients will be randomized to receive morphine plus saline (a placebo) or morphine plus ketamine before the WCP. The second time the patient is scheduled for WCP (no less than 24 hours), patients will be crossed over to receive the treatment they did not receive the first time. It is hypothesized that patients who receive the combination of morphine and ketamine will have better pain control during the procedure than patients who just receive morphine.
Trial arms
Trial start
2008-06-01
Estimated PCD
2009-04-01
Trial end
2009-04-01
Status
Completed
Phase
Early phase I
Treatment
Morphine plus Ketamine
Morphine 0.05 mg/kg (maximum dose of 4 mg) IV plus Ketamine 0.25 mg/kg IV. Then, Morphine 0.1 mg/kg (maximum dose of 8 mg) IV plus Saline IV
Arms:
Morphine plus Ketamine, then Morphine plus Saline (placebo), Morphine plus Saline (placebo), then Morphine plus Ketamine
Morphine plus Saline (placebo)
Morphine 0.1 mg/kg (maximum dose of 8 mg) IV plus Saline IV. Then, Morphine 0.05 mg/kg (maximum dose of 4 mg) IV plus Ketamine 0.25 mg/kg IV.
Arms:
Morphine plus Ketamine, then Morphine plus Saline (placebo), Morphine plus Saline (placebo), then Morphine plus Ketamine
Size
12
Primary endpoint
Pain Intensity
Immediately after the wound care procedure
Eligibility criteria
Inclusion Criteria: * Adults patients (≥ 21 years) have to have an open wound with duration of no more than 10 days that requires wound care * be able to self-report their pain * had a pain intensity score \> 3 during previous wound care procedure * has intravenous access Exclusion Criteria: * Patients with an injury that impairs sensation in the wound area according to a medical diagnosis * has an allergy to morphine or ketamine * has not received morphine previously * In addition, patients who are 65 years of age or older.
Protocol
{'studyType': 'INTERVENTIONAL', 'phases': ['PHASE3'], 'designInfo': {'allocation': 'RANDOMIZED', 'interventionModel': 'CROSSOVER', 'primaryPurpose': 'TREATMENT', 'maskingInfo': {'masking': 'TRIPLE', 'whoMasked': ['PARTICIPANT', 'CARE_PROVIDER', 'INVESTIGATOR']}}, 'enrollmentInfo': {'count': 12, 'type': 'ACTUAL'}}
Updated at
2024-03-26

1 organization

2 products

6 indications

Indication
Wound Care
Indication
Pain Intensity
Indication
Hyperalgesia
Indication
Nausea
Indication
Vomiting
Indication
Hallucinations
Product
Morphine